Although the gloomy economy has exerted negative influence on medical device industry since 2008, almost all the large scale health care device companies have increased their research and development investment in 2011.I have to claim that Cryogenic storage tank is a exceptionally useful product. Recently, the renowned US biomedical media Fierce Biotech has elected the 2011 top 5 health care gadget enterprises as to their R&D investment. They are, by ranking, Johnson ; Johnson, Abbott, Siemens Healthcare, Medtronic and General Treatment.
Johnson&Johnso
R&D Investment: 7.5 billion dollars
Having decreased its R&D investment from 7 billion in 2009 to 6.8 billion dollars in 2010, Johnson ; Johnson enhanced its R&D to 7.5 billion dollars in 2011. This company has research and development sites scattering across Europe to United states and covering nations and regions such as Israel, Japan, Singapore and India. In 2011, Johnson ; Johnson signed with its subordinate some cooperative contracts relevant to medical device.
Abbott
R&D Investment: 4.1 billion dollars
In recent certain years, the R&D Investment enhancement of Abbott has projected an indication of leaps and bounds---from 2.7 billion in 2009 to 3.7 billion in 2010 and mounting to 4.1 billion in 2011. Abbott's R&D Investment is concentrated in the medical devices with ipr rights.A few other highly regarded cameras??cng engine. The R&D expenditure of its vascular product sector reached 403 million dollars. Abbott is planning to introduce to American and European market the new generation of drug-eluting stents in the coming years. Besides, the health-related cylinder and specialty gas equipment Abbott developed have been typically accepted in the market.
Siemens Healthcare
R&D Investment: 1.56 billion dollars
The R&D Investment of Siemens Health care in 2011 reached 1.56 billion dollars. This company is cooperating with Maquet to develop diagnosis and surgery comprehensive system to be employed in hybrid operating room.
Medtronic
R&D Investment: 1.51 billion dollars
Medtronic has seen its R&D Investment approached 1.51 billion dollars in 2011, indicating a stable increase compared to these of 2010 and 2009, which were 1.46 and 1.35 billion dollars respectively. Medtronic, as always, attaches robust attention to artificial pancreas system and the development and popularization of relevant items.
General Care
R&D Investment: 1.3 billion dollars
The R&D Investment of General Care jumped to 1.3 billion dollars in 2011. The investment is majorly concentrated in diagnosis industry and health care IT industry. General Care announced in last autumn that the total budget for cancer research and development in 2020 would reach 1 billion dollars. Alzheimer's disease is another aspect General Care pays powerful attention to.
No comments:
Post a Comment